Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ribociclib
Related studies linked through entity extraction aliases.
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Ribociclib and Bicalutamide in AR+ TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
- Status
- TERMINATED
- Phase
- PHASE3
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
- Status
- COMPLETED
- Phase
- PHASE3
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Next Generation Personalized Neuroblastoma Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2